Purchase Short-Term Access
Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled Trial
Dario Giugliano, MD; Raffaele Marfella, MD; Antonio Quatraro, MD; Nicoletta De Rosa, MD; Teresa Salvatore, MD; Domenico Cozzolino, MD; Antonio Ceriello, MD; Roberto Torella, MD
Annals of Internal Medicine 1993;118:7-11.
doi:10.7326/0003-4819-118-1-199301010-00002
Purchase Online access to this article for 24 hours